Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
2017 · Nature Genetics · 566 citations
https://doi.org/10.1038/ng.3990
R
Richard B. Lanman
C.T. de Wit Graduate School for Production Ecology and Resource Conservation(NL)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
618
Papers
17.0K
Citations
69
h-index
131
i10-index
Richard B. Lanman is an academic researcher from C.T. de Wit Graduate School for Production Ecology and Resource Conservation. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Lung Cancer Treatments and Mutations & Genetic factors in colorectal cancer. The author has an h-index of 69, co-authored 526 publications.
ORCID: 0000-0001-8122-4329Papers by this author
worksAberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer
2019 · Nature Communications · 383 citations
https://doi.org/10.1038/s41467-019-09068-2
Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer
2018 · Cancer Cell · 157 citations
https://doi.org/10.1016/j.ccell.2018.06.004
Plasma HER2 ( <i>ERBB2</i> ) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer
2019 · Clinical Cancer Research · 128 citations
https://doi.org/10.1158/1078-0432.ccr-18-3389
Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for <i>EGFR</i> -Amplified Gastroesophageal Adenocarcinoma
2018 · Cancer Discovery · 117 citations
https://doi.org/10.1158/2159-8290.cd-17-1260
Combined Blockade of Activating <i>ERBB2</i> Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer
2018 · Clinical Cancer Research · 109 citations
https://doi.org/10.1158/1078-0432.ccr-18-1544
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat